BioCep Ltd.
BioCep's rare cell separation capabilities will allow novel therapy developments such as non-invasive prenatal diagnosis in the 1st trimest
- Stage Concept Only
- Industry Biotechnology
- Location Safed, IL
- Currency USD
- Employees 8
- Website biocep.com
Company Summary
BioCep has developed a novel cell separation technology for rare cell isolation facilitating development of novel clinical applications such as prenatal diagnosis, stem cell therapies and disease management. BioCep will market application-specific systems and consumable kits to customers in these fields. BioCEP will partner with entities to develop these various groundbreaking applications. Sales of BioCEP's R&D cell isolation device has begun.
Team
-
Ofer KleinCheif Scientist
-
Doron BirgerChairman of the Board
-
Hannoch MarksheidCEO
-
Aharon LamishCheif Engineer
-
Rachel LeibovitzeBusiness Development Manager
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.